We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
BECKMAN COULTER, INC.

Download Mobile App




Pathology

Image: A histopathology of meningeal carcinomatosis with infiltration of the brain gray matter and perivascular malignant cells (Photo courtesy of Zuzana Gdovinova.

Methylation Signature Identified for Brain Metastases of Lung Cancer

When lung cancer metastasizes to the brain, it means the primary lung cancer has created a secondary cancer in the brain. About 20% to 40% of adults with non-small cell lung cancer go on to develop brain metastases at some point during their illness. More...
17 Oct 2019

Beckman Coulter Early Sepsis Indicator
With the potential to revolutionize emergency department sepsis identification, the Early Sepsis Indicator is a new hematological biomarker helping physicians more confidently assess sepsis or the risk of sepsis in adult patients.
[BECKMAN COULTER, INC.]
Image: A histopathology of high-grade invasive ductal carcinoma of the breast (not otherwise specified, grade 3). This is an example of a triple-negative breast cancer, basal-like carcinoma (Photo courtesy of Lee Moffitt Cancer Center).

Triple-Negative Breast Cancer Classified from Whole-Genome Sequencing

A diagnosis of triple negative breast cancer means that the three most common types of receptors known to fuel most breast cancer growth–estrogen, progesterone and the HER-2/neu gene are not present in the cancer tumor. More...
16 Oct 2019
Mayo Medical Laboratories
Image: Scanning electron photomicrograph (SEM) of breast cancer cells. Unselected, high-risk multigene testing for all patients with breast cancer is extremely cost-effective (Photo courtesy of Marie Thibault).

Multigene Testing for Breast Cancer Patients Proves Cost-Effective

Health systems in the UK and USA could cost-effectively screen all women with breast cancer for risky germline changes in a handful of breast or ovarian cancer genes, according to a new economic modeling analysis, identifying at-risk individuals who could benefit from additional imaging tests and cancer-reducing interventions. More...
16 Oct 2019
Image: A new blood test has been developed capable of detecting multiple cancer types. The new test looks for DNA, which cancer cells shed into the bloodstream when they die (Photo courtesy of weeksnews).

New Blood Test Capable of Detecting Multiple Cancer Types

A new blood test in development has shown ability to screen for numerous types of cancer with a high degree of accuracy, a trial of the test shows. In study, test proved able to detect and localize more than 20 types of cancer with a high degree of accuracy. More...
16 Oct 2019

Confidence with the press of a button
The Magnis NGS Prep System is a walkaway automated solution comprised of a benchtop instrument that self-detects and tunes, pre-aliquoted reagents, and pre-set protocols for library preparation that requires minimal staff and NGS expertise. Learn More.
[AGILENT]
Image: The NovoCyte flow cytometer (Photo courtesy of ACEA Bio).

Blood Monocyte Functions Altered in Parkinson's Disease

Parkinson's disease is characterized by the slow degeneration of the neurons in brain due to the abnormal accumulation of a protein called alpha-synuclein. This leads to the patients shaking and then to the slow, stiff movements which many people associate with the disease. More...
15 Oct 2019
Image: The Gen-S hematology analyzer (Photo courtesy of Beckman Coulter).

Hematological Parameters Detect Patients with Acute VTE

Venous thromboembolism (VTE) encompasses deep venous thrombosis (DVT) and pulmonary embolism (PE). VTE causes cardiovascular death and disability and the risk of PE‐associated mortality and morbidity extends far beyond the acute phase of the disease. More...
08 Oct 2019
Image: The use of RNA-seq as a decentralized methodology at the core of the MammaPrint and BluePrint microarray-based diagnostic technology (Photo courtesy of Agendia).

Targeted RNA Sequencing Technology Diagnoses Breast Cancer

In recent years, RNA-sequencing (RNA-seq) technology has become the standard for transcriptome analysis because of its flexibility, sensitivity, and accuracy in measuring gene expression. RNA-seq is a technology in which cDNA is derived from RNA, followed by library construction and massively parallel deep sequencing. More...
01 Oct 2019

In Other News



The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chemistry
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Lab Tech.
BioResearch
Industry News
Events

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

TradeMed.comHospiMedica.com Globetech.net
Copyright © 2000-2019 Globetech Media. All rights reserved.
MOBILE | FULL SITE